ArtiMed
Baltimore, Maryland, United States
ArtiMed is developing AI-based risk stratification software-as-a-service (SaaS) tools. These tools are designed to assist health plans and insurers to manage the challenges presented by long Covid and other post-Covid conditions within their populations. Additionally, they enable pharmaceutical companies in identifying individuals who might benefit from their drugs for these conditions. ArtiMed has recently expanded its portfolio to broadened its scope to include risk stratification for other post-Covid issues such as major cardiovascular conditions, including myocardial infarction or stroke, associated with a previous Covid infection.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.artimed.ai/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of ArtiMed?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now